Related Experiment Video
Updated: Nov 3, 2025
09:46
Reconstituting Cytoarchitecture and Function of Human Epithelial Tissues on an Open-Top Organ-Chip
Published on: February 17, 2023
2.1K
Harnessing organs-on-a-chip to model tissue regeneration
Daniel Naveed Tavakol1, Sharon Fleischer1, Gordana Vunjak-Novakovic2
1Department of Biomedical Engineering, Columbia University, New York, NY.
Cell Stem Cell
|June 4, 2021
Summary
Tissue engineering advances regenerative medicine. Organ-on-a-chip models using induced pluripotent stem cells (iPSCs) offer patient-specific insights for cardiac, respiratory, and hematopoietic regeneration therapies.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Stem Cell Biology
Background:
- Tissue engineering has evolved significantly since the 1980s.
- Beyond organ regeneration, it now models human physiology in vitro.
- Induced pluripotent stem cell (iPSC) technology facilitates patient-specific disease modeling and regenerative studies.
Purpose of the Study:
- To explore the potential of organ-on-a-chip systems for studying regenerative therapies.
- To focus on cardiac, respiratory, and hematopoietic organ systems.
- To propose a combined approach for translational tissue engineering.
Main Methods:
- Utilizing organ-on-a-chip technology.
- Employing induced pluripotent stem cells (iPSCs).
- Investigating cardiac, respiratory, and hematopoietic systems.
Main Results:
- Organ-on-a-chip systems show promise for studying regenerative therapies.
- Patient-specific iPSC-derived tissues enable personalized disease modeling.
- The study highlights the potential for studying multiple organ systems.
Conclusions:
- Organ-on-a-chip systems combined with iPSC technology can advance regenerative medicine.
- Investigating human tissues at multiple scales is crucial for translational success.
- This approach holds significant potential for developing new therapies for organ damage and disease.
